Characterization of Human T Cells Against Chlamydia
人类 T 细胞抗衣原体的特性
基本信息
- 批准号:6332135
- 负责人:
- 金额:$ 37.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2003-09-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant): Chlamydia trachomatis (Ct) is the most
common cause of bacterial sexually transmitted disease worldwide. In previous
work, we identified epitopes in the major outer membrane (MOMP) that are
recognized by CD4+ T cells in the context of HLA class II molecules and others
that are recognized by CD8+ T cells in the context of HLA class I molecules.
Most recently, we used HLA A2 tetramers to identify MOMP-specific CD8+ T cells
in blood of Ct-infected individuals and found that they killed Ct infected
epithelial cells. We will extend these studies to other individuals using HLA
class I tetramers made with other allotypes. To identify and characterize
MOMP-specific CD4+ T cells isolated from blood, we will create HLA class II
tetramers using MOMP epitopes that are recognized by CD4+ T cells. We will
characterize both CD8 and CD4 MOMP-specific T cells with regard to cell surface
proteins that are involved in homing (e.g. integrins and chemokine receptors),
function (e.g. cytokines, perforin) and state of differentiation (e.g. HLA-DR,
CD62L) by using multi-color flow cytometry with monoclonal antibodies against
cell surface and intracellular proteins. Comparisons of lymphocytes from the
blood vs. sites of infection will provide information on how representative
blood-derived samples are of cells at infected sites. Lastly, the ability of
MOMP-specific CTL to limit the increase of infectious Ct in infected genital
tract cells and the effects of mutations in CTL epitopes on such limitation
will be determined. The ability to detect and characterize human
anti-Chlamydial T cells with tetramers and cellular reagents of defined HLA-
and epitope specificity would be useful for vaccine development, especially
since most of the epitopes are in conserved regions of MOMP.
描述(申请人提供):沙眼衣原体(Ct)最多
世界范围内细菌性传播疾病的常见原因。在以前的
工作中,我们确定了主要外膜(MOMP)中的表位
在人类白细胞抗原II类分子等背景下被CD4+T细胞识别
是由CD8+T细胞在人类白细胞抗原I类分子的背景下识别的。
最近,我们使用HLAA2四聚体来鉴定MOMP特异性CD8+T细胞
在CT感染者的血液中发现他们杀死了CT感染者
上皮细胞。我们将把这些研究扩展到其他使用人类白细胞抗原的个体
用其他同种异型制成的第I类四聚体。识别和刻画
从血液中分离出MOMP特异性的CD4+T细胞,我们将创建人类白细胞抗原II类
使用可被CD4+T细胞识别的MOMP表位的四聚体。我们会
CD8和CD4MOMP特异性T细胞的细胞表面特征
参与归巢的蛋白质(例如整合素和趋化因子受体),
功能(如细胞因子、穿孔素)和分化状态(如HLA-DR、
CD62L),用抗CD62L的单抗进行多色流式细胞术
细胞表面和细胞内的蛋白质。不同来源的淋巴细胞的比较
血液与感染部位的对比将提供有关代表性的信息
血液样本是感染部位的细胞。最后,我们有能力
MOMP特异性CTL抑制感染生殖器中感染性CT的增加
TRAIL细胞及其CTL表位突变对这种限制的影响
将会被确定。检测和描述人类特征的能力
抗衣原体T细胞与四聚体和确定的人类白细胞抗原-1细胞试剂
表位特异性将有助于疫苗的开发,特别是
因为大多数表位位于MOMP的保守区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paula B. Kavathas其他文献
Paula B. Kavathas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paula B. Kavathas', 18)}}的其他基金
Characterization of Human T Cells Against Chlamydia
人类 T 细胞抗衣原体的特性
- 批准号:
7225225 - 财政年份:2004
- 资助金额:
$ 37.17万 - 项目类别:
Characterization of Human T Cells Against Chlamydia
人类 T 细胞抗衣原体的特性
- 批准号:
6891090 - 财政年份:2004
- 资助金额:
$ 37.17万 - 项目类别:
Characterization of Human T Cells Against Chlamydia
人类 T 细胞抗衣原体的特性
- 批准号:
6738934 - 财政年份:2004
- 资助金额:
$ 37.17万 - 项目类别:
Characterization of Human T Cells Against Chlamydia
人类 T 细胞抗衣原体的特性
- 批准号:
7052078 - 财政年份:2004
- 资助金额:
$ 37.17万 - 项目类别:
Characterization of Human T Cells Against Chlamydia
人类 T 细胞抗衣原体的特性
- 批准号:
7414396 - 财政年份:2004
- 资助金额:
$ 37.17万 - 项目类别:
ALLERGY, IMMUNOLOGY & TRANSPLANTATION RESEARCH COMMITTEE
过敏、免疫学
- 批准号:
6595161 - 财政年份:1995
- 资助金额:
$ 37.17万 - 项目类别:
ALLERGY, IMMUNOLOGY & TRANSPLANTATION RESEARCH COMMITTEE
过敏、免疫学
- 批准号:
6468845 - 财政年份:1995
- 资助金额:
$ 37.17万 - 项目类别:
相似海外基金
Investigating whether chlamydia trachomatis can increase the infectivity of HPV during genital tract infections
研究沙眼衣原体是否可以增加生殖道感染期间 HPV 的传染性
- 批准号:
10648156 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Development of a multivalent rVSV vaccine against different Chlamydia trachomatis urogenital infections
针对不同沙眼衣原体泌尿生殖道感染的多价 rVSV 疫苗的开发
- 批准号:
488750 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Operating Grants
Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
鉴定介导 PD-L1 上调的沙眼衣原体因子
- 批准号:
10724569 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening
直肠沙眼衣原体感染对无直肠筛查指征的女性免疫和泌尿生殖感染事件的影响
- 批准号:
10703789 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis.
了解马达如何驱动感染沙眼衣原体的宿主细胞的发病机制。
- 批准号:
491115 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Fellowship Programs
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection
沙眼衣原体特异性 HLA-E 限制性 CD8 T 细胞反应在感染清除中的作用
- 批准号:
10646837 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
CRISPR interference of essential stage-specific gene function in Chlamydia trachomatis
CRISPR 干扰沙眼衣原体必需阶段特异性基因功能
- 批准号:
10644789 - 财政年份:2023
- 资助金额:
$ 37.17万 - 项目类别:
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
宫颈阴道微生物群、粘膜免疫和有助于沙眼衣原体自发清除的病原体因素
- 批准号:
10463072 - 财政年份:2022
- 资助金额:
$ 37.17万 - 项目类别:
iSampleSmart!, an innovative, App-facilitated self-sampling screen and treat strategy for common bacterial STIs (Chlamydia trachomatis and Neisseria gonorrhoeae) for Canadian key populations
iSampleSmart!,一种创新的、应用程序辅助的自我采样筛查和治疗策略,适用于加拿大重点人群的常见细菌性传播感染(沙眼衣原体和淋病奈瑟菌)
- 批准号:
472740 - 财政年份:2022
- 资助金额:
$ 37.17万 - 项目类别:
Operating Grants
Dissecting the role of the Inclusion membrane protein IncE, a master multi-tasking scaffolding protein, in the pathogenesis of Chlamydia trachomatis infections
剖析包涵膜蛋白 IncE(一种主要的多任务支架蛋白)在沙眼衣原体感染发病机制中的作用
- 批准号:
10453533 - 财政年份:2022
- 资助金额:
$ 37.17万 - 项目类别: